You are here
News
Genome Canada welcomes two new Board members
Thursday, June 25, 2020
Drs. Elizabeth Douville (Chair of the Board of Directors) and Rob Annan (President and CEO) are pleased to announce the appointment of Dr. Bonnie Schmidt and Mr. Andrew Stephens to Genome Canada’s Board of Directors for two-year terms. Dr. Douville and existing Board members Mr. Eric Cook and Dr. Jacques Simoneau were reappointed for additional two-year terms.
New Executive Director, CanCOGeN
Monday, June 22, 2020
Genome Canada is pleased to welcome Dr. Catalina Lopez-Correa as Executive Director, Canadian COVID Genomics Network (CanCOGeN), effective June 22, 2020.
Fourteen AI research projects join the fight against COVID-19
Tuesday, May 12, 2020
Projects include machine learning research and applications to identify potential treatments, to support public health measures such as social distancing, and to better understand the viral transmission of COVID-19.
Fourteen new AI research projects will be launched to address the COVID-19 outbreak through CIFAR’s AI and COVID-19 Catalyst Grants initiative.
The COVID-19 Genomics UK (COG-UK) consortium and the Canadian COVID Genomics Network (CanCOGeN) launch new partnership
Monday, May 4, 2020
COG-UK and CanCOGeN are working together to share knowledge and protocols
Genome Canada leads $40 million genomics initiative to address COVID-19 pandemic
Thursday, April 23, 2020
New Canadian network will undertake viral and host genome sequencing to improve patient outcomes
Genome Canada launches additional rapid response funding for COVID-19 research
Thursday, April 2, 2020
Genome Canada today launched another rapid response funding opportunity to invest in research with real potential to address near-term challenges related to the COVID-19 pandemic.